4.8 Article

Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer

期刊

NATURE MEDICINE
卷 25, 期 10, 页码 1549-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41591-019-0592-2

关键词

-

资金

  1. Cancer Immunotherapy Accelerator Award [C33499/A20265]
  2. CRUK's Lung Cancer Centre of Excellence [C5759/A20465]
  3. National Institute for Health Research UCL Hospitals Biomedical Research Centre
  4. Cancer Research UK (CRUK)
  5. CRUK Senior Cancer Research Fellowship [C36463/A22246]
  6. Sam Keen Foundation
  7. Institute of Cancer Research Biomedical Research Centre
  8. Royal Marsden Cancer Charity
  9. UCL Biomedical Research Centre
  10. Cancer Research UK studentship
  11. MRC Clinical Infrastructure award [MR/M009033/1]
  12. Rosetrees and Stoneygate Trust [A1388]
  13. CRUK Biotherapeutics Programme grant [C36463/A20764]
  14. Khoo Teck Puat UK Foundation via the UCL Cancer Institute Research Trust [539288]
  15. ERC [StG 677268 NextDART]
  16. Royal Society Napier Research Professor
  17. Francis Crick Institute
  18. Cancer Research UK
  19. UK Medical Research Council [FC001169]
  20. Wellcome Trust [FC001169]
  21. CRUK Cancer Immunotherapy Catalyst Network
  22. CRUK Lung Cancer Centre of Excellence, Stand Up 2 Cancer (SU2C)
  23. Rosetrees Trust
  24. Stoneygate Trusts
  25. NovoNordisk Foundation [ID16584]
  26. Prostate Cancer Foundation
  27. Breast Cancer Research Foundation (BCRF)
  28. European Research Council (ERC) [FP7-THESEUS-617844]
  29. European Commission ITN [607722]
  30. ERC Advanced Grant (PROTEUS) from the European Research Council under the European Union [835297]
  31. National Institute for Health Research
  32. University College London Hospitals Biomedical Research Centre
  33. Cancer Research UK University College London Experimental Cancer Medicine Centre
  34. MRC [MR/N000838/1, MR/M009033/1] Funding Source: UKRI
  35. The Francis Crick Institute [10233] Funding Source: researchfish

向作者/读者索取更多资源

Somatic mutations together with immunoediting drive extensive heterogeneity within non-small-cell lung cancer (NSCLC). Herein we examine heterogeneity of the T cell antigen receptor (TCR) repertoire. The number of TCR sequences selectively expanded in tumors varies within and between tumors and correlates with the number of nonsynonymous mutations. Expanded TCRs can be subdivided into TCRs found in all tumor regions (ubiquitous) and those present in a subset of regions (regional). The number of ubiquitous and regional TCRs correlates with the number of ubiquitous and regional nonsynonymous mutations, respectively. Expanded TCRs form part of clusters of TCRs of similar sequence, suggestive of a spatially constrained antigen-driven process. CD8(+) tumor-infiltrating lymphocytes harboring ubiquitous TCRs display a dysfunctional tissue-resident phenotype. Ubiquitous TCRs are preferentially detected in the blood at the time of tumor resection as compared to routine follow-up. These findings highlight a noninvasive method to identify and track relevant tumor-reactive TCRs for use in adoptive T cell immunotherapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据